Literature DB >> 24182829

De novo membranous nephropathy in renal allograft associated with antibody-mediated rejection and review of the literature.

K Patel1, J Hirsch, L Beck, L Herlitz, J Radhakrishnan.   

Abstract

A 71-year-old woman with unknown renal failure etiology received living donor transplantation had normal graft function for many years. At 11 years from transplantation, she developed nephrotic syndrome. Allograft biopsy showed membranous nephropathy (MN) and C4d positivity in the peritubular capillaries, suggestive of antibody-mediated rejection. At the time of nephrosis onset, she had new donor-specific antibody positivity. The case is unusual in that the diagnosis of de novo MN is based on evidence that she had antibody-mediated rejection. De novo MN remains relatively uncommon; we have reviewed the literature on this diagnosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24182829     DOI: 10.1016/j.transproceed.2013.05.011

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

1.  A rare cause of proteinuria after kidney transplantation: Answers.

Authors:  Nilüfer Göknar; Seha Saygılı; Nur Canpolat; Yasemin Özlük; Işın Kılıçaslan; Lale Sever; Salim Çalışkan
Journal:  Pediatr Nephrol       Date:  2019-04-30       Impact factor: 3.714

2.  A Case of De Novo Membranous Nephropathy Causing Renal Transplant Rejection.

Authors:  Sarah C Kurkowski; Michael J Thimmesch; Amro Abdelghani; Yasir H Abdelgadir
Journal:  Cureus       Date:  2022-06-23

3.  Relapsing De Novo Membranous Nephropathy.

Authors:  Ala Ali; Huda Al-Taee; Thaer J Kadhim
Journal:  Case Rep Transplant       Date:  2022-05-02

4.  The Association Between Post-Kidney Transplant De Novo Glomerulonephritis and Alloimmunity.

Authors:  Pascale Khairallah; Jeanne Kamal; Russell J Crew; Geo Serban; Elena-Rodica Vasilescu; Geoffrey K Dube; Ibrahim Batal
Journal:  Kidney Int Rep       Date:  2021-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.